HUCOG 10000 IU is an injectable form of human chorionic gonadotropin (hCG), a hormone widely used in reproductive medicine. It plays a crucial role in both female fertility treatments and male hypogonadism management by mimicking the natural luteinizing hormone (LH) surge in the body.
In women, HUCOG is used to trigger ovulation during assisted reproductive techniques (ART) such as in vitro fertilization (IVF), intrauterine insemination (IUI), and other ovulation induction protocols. In men, it is used to stimulate testosterone production and improve sperm count in cases of hypogonadism or delayed puberty.
HUCOG 10000 IU is administered by intramuscular (IM) or subcutaneous injection, typically under the supervision of a fertility specialist or healthcare provider.
✅ Ovulation Induction in Women — triggers the final maturation and release of eggs (ovulation) in infertility treatment cycles
✅ Assisted Reproductive Techniques (ART) — such as IVF and IUI, to ensure proper timing of egg retrieval or insemination
✅ Male Hypogonadism — stimulates Leydig cells in the testes to boost testosterone production and improve fertility
✅ Cryptorchidism in Boys — helps descend undescended testicles in certain pediatric cases
Effective ovulation trigger: Ensures proper egg release for successful fertilization during ART cycles.
Supports male fertility: Boosts sperm production and testosterone levels in men with hypogonadism.
Well-established treatment: Widely used in reproductive medicine with proven outcomes.
Versatile use: Can be used in both men and women under medical supervision.
HUCOG contains human chorionic gonadotropin, which closely mimics the action of luteinizing hormone (LH) in the body.
In women, the hCG surge triggers ovulation by promoting the final maturation of ovarian follicles and supporting luteal phase function.
In men, hCG stimulates the Leydig cells in the testes to produce testosterone, enhancing spermatogenesis and improving fertility outcomes.
In women (for ovulation induction): Typically 5000–10,000 IU injected once, usually 24–48 hours before ovulation or egg retrieval.
In men (for hypogonadism or infertility): Commonly 1000–2000 IU, 2–3 times per week, as per doctor’s prescription.
Administration: By intramuscular (IM) or subcutaneous injection, performed by a healthcare provider or trained patient (if instructed).
HUCOG 10000 IU is an injectable form of human chorionic gonadotropin (hCG), a hormone widely used in reproductive medicine. It plays a crucial role in both female fertility treatments and male hypogonadism management by mimicking the natural luteinizing hormone (LH) surge in the body.
In women, HUCOG is used to trigger ovulation during assisted reproductive techniques (ART) such as in vitro fertilization (IVF), intrauterine insemination (IUI), and other ovulation induction protocols. In men, it is used to stimulate testosterone production and improve sperm count in cases of hypogonadism or delayed puberty.
HUCOG 10000 IU is administered by intramuscular (IM) or subcutaneous injection, typically under the supervision of a fertility specialist or healthcare provider.
✅ Ovulation Induction in Women — triggers the final maturation and release of eggs (ovulation) in infertility treatment cycles
✅ Assisted Reproductive Techniques (ART) — such as IVF and IUI, to ensure proper timing of egg retrieval or insemination
✅ Male Hypogonadism — stimulates Leydig cells in the testes to boost testosterone production and improve fertility
✅ Cryptorchidism in Boys — helps descend undescended testicles in certain pediatric cases
Effective ovulation trigger: Ensures proper egg release for successful fertilization during ART cycles.
Supports male fertility: Boosts sperm production and testosterone levels in men with hypogonadism.
Well-established treatment: Widely used in reproductive medicine with proven outcomes.
Versatile use: Can be used in both men and women under medical supervision.
HUCOG contains human chorionic gonadotropin, which closely mimics the action of luteinizing hormone (LH) in the body.
In women, the hCG surge triggers ovulation by promoting the final maturation of ovarian follicles and supporting luteal phase function.
In men, hCG stimulates the Leydig cells in the testes to produce testosterone, enhancing spermatogenesis and improving fertility outcomes.
In women (for ovulation induction): Typically 5000–10,000 IU injected once, usually 24–48 hours before ovulation or egg retrieval.
In men (for hypogonadism or infertility): Commonly 1000–2000 IU, 2–3 times per week, as per doctor’s prescription.
Administration: By intramuscular (IM) or subcutaneous injection, performed by a healthcare provider or trained patient (if instructed).